| scholarly article | Q13442814 |
| P356 | DOI | 10.3389/FPHYS.2016.00293 |
| P8608 | Fatcat ID | release_l2cqf3uedjaxpichsgvxrtag4m |
| P932 | PMC publication ID | 4941796 |
| P698 | PubMed publication ID | 27462276 |
| P50 | author | Rafael Dariolli | Q54562514 |
| P2093 | author name string | Ednei L Antonio | |
| Paulo J F Tucci | |||
| Adriana C C Girardi | |||
| Leonardo Dos Santos | |||
| Daniel F Arruda-Junior | |||
| Leonardo Jensen | |||
| Flavia L Martins | |||
| P2860 | cites work | Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome | Q24314612 |
| Defective forebrain development in mice lacking gp330/megalin | Q24629015 | ||
| NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome | Q28116208 | ||
| A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate | Q28202635 | ||
| Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm | Q28611496 | ||
| Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency | Q28740948 | ||
| Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations | Q29304271 | ||
| Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
| Nephrin in experimental glomerular disease. | Q31442523 | ||
| Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice | Q33750640 | ||
| The effects of heart failure on renal function | Q33996089 | ||
| The prognostic significance of renal dysfunction in patients with chronic systolic heart failure | Q35105833 | ||
| Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. | Q35189265 | ||
| Megalin knockout mice as an animal model of low molecular weight proteinuria. | Q35788270 | ||
| Neurohormonal activation in congestive heart failure and the role of vasopressin | Q36104992 | ||
| Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice | Q36312680 | ||
| Renal albumin absorption in physiology and pathology | Q36412414 | ||
| Cardiovascular biology of the incretin system | Q36484283 | ||
| Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat. | Q36527908 | ||
| Neurohumoral activation in heart failure: the role of adrenergic receptors. | Q36579463 | ||
| Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up | Q36758314 | ||
| Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction | Q37277960 | ||
| Deciphering the mechanisms of the Na+/H+ exchanger-3 regulation in organ dysfunction. | Q37998392 | ||
| Changes in renal function in congestive heart failure | Q38155422 | ||
| Dipeptidyl peptidase-4 inhibitors in progressive kidney disease | Q38270324 | ||
| Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial | Q38424163 | ||
| Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure | Q38787227 | ||
| Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen | Q39020537 | ||
| Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes | Q39600857 | ||
| The contributions of dipeptidyl peptidase IV to inflammation in heart failure. | Q39751432 | ||
| Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. | Q39990285 | ||
| Use of phospho-specific antibodies to determine the phosphorylation of endogenous Na+/H+ exchanger NHE3 at PKA consensus sites. | Q40462710 | ||
| The physiological role of glucagon-like peptide-1 in the regulation of renal function | Q40976120 | ||
| Dipeptidyl peptidase IV, a kidney brush-border serine peptidase | Q41828139 | ||
| Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture | Q42029413 | ||
| Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways | Q42165735 | ||
| Anaesthetic concerns in an infant with a rare genetic condition; chromosome 9p22 deletion syndrome | Q42906564 | ||
| Posttranslational mechanisms associated with reduced NHE3 activity in adult vs. young prehypertensive SHR. | Q42970295 | ||
| Progression of microalbuminuria in SHR is associated with lower expression of critical components of the apical endocytic machinery in the renal proximal tubule. | Q43547877 | ||
| Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury | Q43574002 | ||
| Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats. | Q43592968 | ||
| Left ventricle radio-frequency ablation in the rat: a new model of heart failure due to myocardial infarction homogeneous in size and low in mortality. | Q44395038 | ||
| Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men. | Q44924385 | ||
| Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rate | Q45361069 | ||
| Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men. | Q45730273 | ||
| Determination of myocardial infarction size in rats by echocardiography and tetrazolium staining: correlation, agreements, and simplifications | Q46774706 | ||
| Dipeptidyl peptidase IV inhibition downregulates Na+ - H+ exchanger NHE3 in rat renal proximal tubule. | Q46852265 | ||
| The novel DPP-4 inhibitors linagliptin and BI 14361 reduce infarct size after myocardial ischemia/reperfusion in rats | Q47334247 | ||
| Changes in nuclear size of cardiac myocytes during the development and progression of hypertrophy in rats. | Q47370382 | ||
| Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure. | Q47914982 | ||
| Glucagon-like peptide-1 is involved in sodium and water homeostasis in humans | Q48440967 | ||
| Sitagliptin reduces albuminuria in patients with type 2 diabetes. | Q51382706 | ||
| The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy. | Q52853506 | ||
| Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis. | Q53223564 | ||
| DA-1229, a dipeptidyl peptidase IV inhibitor, protects against renal injury by preventing podocyte damage in an animal model of progressive renal injury. | Q53797319 | ||
| Changes in the activity and expression of protein phosphatase-1 accompany the differential regulation of NHE3 before and after the onset of hypertension in spontaneously hypertensive rats. | Q54216355 | ||
| Renal nerve stimulation leads to the activation of the Na+/H+ exchanger isoform 3 via angiotensin II type I receptor. | Q54292350 | ||
| Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1. | Q54588963 | ||
| Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy | Q56969922 | ||
| Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure | Q57097937 | ||
| Renal effects of glucagon-like peptide in rats | Q57218990 | ||
| Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow | Q58447525 | ||
| Association of Na(+)-H(+) exchanger isoform NHE3 and dipeptidyl peptidase IV in the renal proximal tubule | Q74599385 | ||
| Pathophysiology of sodium and water retention in heart failure | Q77531997 | ||
| Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats | Q82186212 | ||
| Increased NHE3 abundance and transport activity in renal proximal tubule of rats with heart failure | Q82228645 | ||
| Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria | Q86048317 | ||
| Podocyte biology: Phosphorylation preserves podocytes | Q87385304 | ||
| Dipeptidyl peptidase-4 modulates left ventricular dysfunction in chronic heart failure via angiogenesis-dependent and -independent actions | Q87408607 | ||
| Expression of MicroRNA-29 and Collagen in Cardiac Muscle after Swimming Training in Myocardial-Infarcted Rats | Q87467869 | ||
| P304 | page(s) | 293 | |
| P577 | publication date | 2016-07-12 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure | |
| P478 | volume | 7 |
| Q64252227 | Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease |
| Q47699621 | Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice |
| Q42876331 | Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes |
| Q92486237 | Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose-escalating trial |
| Q39050197 | Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort |
Search more.